The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells

被引:0
|
作者
Gohar Karapetyan
Katarine Fereshetyan
Hayk Harutyunyan
Konstantin Yenkoyan
机构
[1] Yerevan State Medical University named after M. Heratsi,Neuroscience Laboratory, Cobrain Center
[2] Yerevan State Medical University named after M. Heratsi,Department of Biochemistry
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD) is a type of dementia that affects memory, thinking and behavior. Symptoms eventually become severe enough to interfere with daily tasks. Understanding the etiology and pathogenesis of AD is necessary for the development of strategies for AD prevention and/or treatment, and modeling of this pathology is an important step in achieving this goal. β-amyloid peptide (Aβ) injection is a widely used approach for modeling AD. Nevertheless, it has been reported that the model constructed by injection of Aβ in combination with a prooxidant cocktail (ferrous sulfate, Aβ, and buthionine sulfoximine (BSO) (FAB)) best reflects the natural development of this disease. The relationship between oxidative stress and Aβ deposition and their respective roles in Aβ-induced pathology in different animal models of AD have been thoroughly investigated. In the current paper, we compared the effects of Aβ 1-42 alone with that of Aβ-associated oxidative stress induced by the FAB cocktail on the neurodegeneration of hippocampal cells in vitro. We constructed a FAB-induced AD model using rat primary hippocampal cells and analyzed the contribution of each compound. The study mainly focused on the prooxidant aspects of AD pathogenesis. Moreover, cellular bioenergetics was assessed and routine metabolic tests were performed to determine the usefulness of this model. The data clearly show that aggregated Aβ1-42 alone is significantly less toxic to hippocampal cells. Aggregated Aβ damages neurons, and glial cells proliferate to remove Aβ from the hippocampus. External prooxidant agents (Fe2+) or inhibition of internal antioxidant defense by BSO has more toxic effects on hippocampal cells than aggregated Aβ alone. Moreover, hippocampal cells fight against Aβ-induced damage more effectively than against oxidative damage. However, the combination of Aβ with external oxidative damage and inhibition of internal antioxidant defense is even more toxic, impairs cellular defense systems, and may mimic the late phase of AD-associated cell damage. Our findings strongly indicate a critical role for the combination of Aβ and oxidative stress in the development of neurodegeneration in vitro.
引用
收藏
相关论文
共 50 条
  • [1] The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer's disease-like neurodegeneration of hippocampal cells
    Karapetyan, Gohar
    Fereshetyan, Katarine
    Harutyunyan, Hayk
    Yenkoyan, Konstantin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Author Correction: The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
    Gohar Karapetyan
    Katarine Fereshetyan
    Hayk Harutyunyan
    Konstantin Yenkoyan
    Scientific Reports, 12 (1)
  • [3] The synergy of beta amyloid 1-42 and oxidative stress in the development of Alzheimer's disease-like neurodegeneration of hippocampal cells (Vol 12, 21622, 2022)
    Karapetyan, Gohar
    Fereshetyan, Katarine
    Harutyunyan, Hayk
    Yenkoyan, Konstantin
    SCIENTIFIC REPORTS, 2022, 12 (01):
  • [4] Amyloid β-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain
    Butterfield, DA
    Boyd-Kimball, D
    BRAIN PATHOLOGY, 2004, 14 (04) : 426 - 432
  • [5] Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity:: Implications for neurodegeneration in Alzheimer's disease brain.: A review
    Butterfield, DA
    FREE RADICAL RESEARCH, 2002, 36 (12) : 1307 - 1313
  • [6] On methionine and Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress
    Butterfield, DA
    Varadarajan, S
    Aksenova, M
    Link, C
    Yatin, SM
    NEUROBIOLOGY OF AGING, 1999, 20 (03) : 339 - 342
  • [7] Amyloid β-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease grain:: Mechanisms and consequences
    Butterfield, DA
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (24) : 2651 - 2659
  • [8] In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)
    Yatin, SM
    Varadarajan, S
    Link, CD
    Butterfield, DA
    NEUROBIOLOGY OF AGING, 1999, 20 (03) : 325 - 330
  • [9] Amyloid β-Peptide (1-42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
    Butterfield, D. Allan
    Swomley, Aaron M.
    Sultana, Rukhsana
    ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (08) : 823 - 835
  • [10] Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease
    Karthick, Chennakesavan
    Nithiyanandan, Saravanan
    Essa, Musthafa Mohamed
    Guillemin, Gilles J.
    Jayachandran, Swaminathan K.
    Anusuyadevi, Muthuswamy
    NEUROLOGICAL RESEARCH, 2019, 41 (02) : 139 - 150